Barcode, Thanks again for sharing. You consistently take DD to another level.

This would explain why they continue to mention NuroPro IP on their PRs and shows up on PPT "AMBS also owns intellectual property for the diagnosis of Parkinson's disease NuroPro)", but never any news as to progress. If it was in any kind of litigation, that would make sense. Or they are very busy with other opportunities, but still see plenty of value.